Now live: Pro — the full 13F research suite for serious investorsSee pricing →
ADAMS STREET PARTNERS LLC

Q1 2025 · 13F-HR

ADAMS STREET PARTNERS LLCholdings as filed

Filed 2025-05-14 · accession 0001104659-25-048414

$113.0M
Reported value
7
Positions
2025-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
76674Q107RMNIRimini Street, Inc.$82.0M72.6%23,565,433CommonSOLE
697947109PVLAPalvella Therapeutics, Inc.$11.5M10.2%409,666CommonSOLE
221015100CRVSCorvus Pharmaceuticals, Inc.$10.4M9.22%3,275,616CommonSOLE
91854V107Vacasa, Inc.$5.0M4.47%938,221CommonSOLE
70439P108PAYPaymentus Holdings, Inc.$1.9M1.69%72,968CommonSOLE
48553T106BZKanzhun Limited$1.7M1.48%87,157CommonSOLE
88023B103TEMTempus AI, Inc.$446,9920.40%9,266CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.